J Korean Endocr Soc.  2006 Oct;21(5):370-372. 10.3803/jkes.2006.21.5.370.

Post-transplantation Diabetes Mellitus

• Yoon KH

• KMID: 1511985
• DOI: http://doi.org/10.3803/jkes.2006.21.5.370

Abstract

No abstract available.

MeSH Terms

Diabetes Mellitus*

Reference

1. Mora PF. Post-transplantation diabetes mellitus. Am J Med Sci. 2005. 329:86–94.

2. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes. Diabetes Care. 2002. 25:583–592.

3. Ruiz JO, Simmons RL, Callender CO, Kjellstrand CM, Buselmeier TJ, Najarian JS. Steroid diabetes in renal transplant recipients: pathogenic factors and prognosis. Surgery. 1973. 73:759–765.

4. Mathew TJ, Rao M, Job V, Ratnaswamy S, Jacob CK. Post-transplant hyperglycaemia: a study of risk factors. Nephrol Dial Transplant. 2003. 18:164–171.

5. Depczynski B, Daly B, Campbell LV, Chisholm DJ, Keogh A. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med. 2000. 17:15–19.

6. Hathaway DK, Tolley EA, Blakely ML, Winsett RP, Gaber AO. Development of an index to predict post transplant diabetes mellitus. Clin Transplant. 1993. 7:330–338.

7. Navasa M, Bustamante J, Marroni C, Gonzalez E, Andreu H, Esmatjes E, Garcia-Valdecasas JC, Grande L, Cirera I, Rimola A, Rodes J. Diabetes mellitus after liver transplantation: prevalence and predictive factor. J Hepatol. 1995. 25:64–71.

8. Nieuwenhuis MG. Predictability and other aspects of posttransplant diabetes mellitus in heart transplant recipients. J Heart Lung Transplant. 2001. 20:703–708.

9. Hur KY, Kim MS, Nam JH, Kang ES, Lee HJ, Kim SH, Han SJ, Cha BS, Ahn CW, Kim SI, Kim YS, Lee HC. Contributing factors to different natural courses of posttransplantation diabetes mellitus in renal allograft recipients. J Kor Endocrinol Soc. 2006. 21:373–381.

10. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest. 1981. 67:563–568.

11. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross talk between iron metabolism and diabetes. Diabetes. 2002. 51:2348–2354.

12. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the Unites States. Ann Intern Med. 2000. 133:592–599.

13. Bigam DL, Pennington JJ, Carpentier A, Wanless IR, Hemming AW, Croxford R, Greig PD, Lilly LB, Heathcote JE, Levy GA, Cattral MS. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology. 2000. 32:87–90.

14. Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, Stevenson JC, Coats AJ. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997. 30:527–532.

15. Olefsky JM. Effects of glucocorticoids on carbohydrate metabolism. Am J Med Sci. 1976. 271:202–210.

16. Kasiske B, Gilbertson D, Matas A. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003. 3:178–185.

17. Menegazzo LA, Ursich MJ, Fukui RT, Rocha DM, Silva ME, Ianhez LE, Sabbaga E, Wajchenberg BL. Mechanism of the diabetogenic action of cyclosporin A. Horm Metab Res. 1998. 30:663–667.

18. Bani-Sacchi T, Bani D, Filipponi F, Michel A, Houssin D. Immunocytochemical and ultrastructural changes of islet cells in rats treated long-term with cyclosporine at immunotherapeutic doses. Transplantation. 1990. 49:982–987.

19. Hirano Y, Fujihira S, Ohara K, Katsuki S, Noguchi H. Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation. 1992. 53:889–894.

20. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract. 2004. 66:suppl 1. S37–S43.

21. Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 2001. 50:590–593.